東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

FindBook

Google Book

Amazon

博客來

In Patients Undergoing General Anesthesia, How Does the Use of Nitric Oxide Compare to the Use of Prostacyclin for Intraoperative Management of Pulmonary Hypertension.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	In Patients Undergoing General Anesthesia, How Does the Use of Nitric Oxide Compare to the Use of Prostacyclin for Intraoperative Management of Pulmonary Hypertension./
作者:	Jones, Anesha.
其他作者:	Lyles, Raven
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2021,
面頁冊數:	35 p.
附註:	Source: Dissertations Abstracts International, Volume: 83-02, Section: B.
Contained By:	Dissertations Abstracts International83-02B.
標題:	Nursing. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28643961
ISBN:	9798535510323

In Patients Undergoing General Anesthesia, How Does the Use of Nitric Oxide Compare to the Use of Prostacyclin for Intraoperative Management of Pulmonary Hypertension.
Jones, Anesha.

In Patients Undergoing General Anesthesia, How Does the Use of Nitric Oxide Compare to the Use of Prostacyclin for Intraoperative Management of Pulmonary Hypertension. - Ann Arbor : ProQuest Dissertations & Theses, 2021 - 35 p.

Source: Dissertations Abstracts International, Volume: 83-02, Section: B.

Thesis (D.N.P.)--Franciscan Missionaries of Our Lady University, 2021.

This item must not be sold to any third party vendors.

Purpose: The purpose of this systematic review was to determine which inhaled pulmonary vasodilator (inhaled nitric oxide or inhaled prostacyclin) was superior in reducing pulmonary artery pressures (PAPs) in patients undergoing general anesthesia (GA).Methodology: An in-depth literature search was completed on peer-reviewed journal articles published between January 2000-August 2020. The electronic databases searched include EBSOhost, CINHAL, Science Direct, MEDline, and ProQuest. Google Scholar was also utilized to identify additional studies. Results: The primary outcome measured was mean PAP. These studies also included secondary outcome measures that included hypoxemia, central venous pressure (CVP), pulmonary vascular resistance (PVR), cardiac index (CI), cardiac output (CO), and mixed venous oxygenation (SvO2). The results showed that, when comparing iNO and PGI2, there was no significant difference in PAP in patients undergoing GA. The comparisons revealed similar results in reduction of PAP and PVR. The researchers failed to find consistent evidence to support a change in practice regarding the intraoperative management of pulmonary hypertension.Implications for Practice and Research: The finding of this systematic review did not support a change in practice. The decision to use either iNO or PGI2 should be based on multiple factors including anesthesia provider preference, facility training, and cost. More rigorous studies such as randomized control trials (RCTs), should be conducted with large, diverse samples comparing the intraoperative use of iNO and PGI2 to treat pulmonary hypertension.

ISBN: 9798535510323Subjects--Topical Terms:

528444
Nursing.
Subjects--Index Terms:

General anesthesia

In Patients Undergoing General Anesthesia, How Does the Use of Nitric Oxide Compare to the Use of Prostacyclin for Intraoperative Management of Pulmonary Hypertension.
LDR:02978nmm a2200409 4500 001 2345991
005 20220613064831.5
008 241004s2021 ||||||||||||||||| ||eng d
020 $a 9798535510323
035 $a (MiAaPQ)AAI28643961
035 $a AAI28643961
040 $a MiAaPQ $c MiAaPQ
100 1 $a Jones, Anesha. $3 3685012
245 1 0 $a In Patients Undergoing General Anesthesia, How Does the Use of Nitric Oxide Compare to the Use of Prostacyclin for Intraoperative Management of Pulmonary Hypertension.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2021
300 $a 35 p.
500 $a Source: Dissertations Abstracts International, Volume: 83-02, Section: B.
500 $a Advisor: Dorn, Callie S.
502 $a Thesis (D.N.P.)--Franciscan Missionaries of Our Lady University, 2021.
506 $a This item must not be sold to any third party vendors.
520 $a Purpose: The purpose of this systematic review was to determine which inhaled pulmonary vasodilator (inhaled nitric oxide or inhaled prostacyclin) was superior in reducing pulmonary artery pressures (PAPs) in patients undergoing general anesthesia (GA).Methodology: An in-depth literature search was completed on peer-reviewed journal articles published between January 2000-August 2020. The electronic databases searched include EBSOhost, CINHAL, Science Direct, MEDline, and ProQuest. Google Scholar was also utilized to identify additional studies. Results: The primary outcome measured was mean PAP. These studies also included secondary outcome measures that included hypoxemia, central venous pressure (CVP), pulmonary vascular resistance (PVR), cardiac index (CI), cardiac output (CO), and mixed venous oxygenation (SvO2). The results showed that, when comparing iNO and PGI2, there was no significant difference in PAP in patients undergoing GA. The comparisons revealed similar results in reduction of PAP and PVR. The researchers failed to find consistent evidence to support a change in practice regarding the intraoperative management of pulmonary hypertension.Implications for Practice and Research: The finding of this systematic review did not support a change in practice. The decision to use either iNO or PGI2 should be based on multiple factors including anesthesia provider preference, facility training, and cost. More rigorous studies such as randomized control trials (RCTs), should be conducted with large, diverse samples comparing the intraoperative use of iNO and PGI2 to treat pulmonary hypertension.
590 $a School code: 2035.
650 4 $a Nursing. $3 528444
650 4 $a Pharmacology. $3 634543
650 4 $a Surgery. $3 707153
650 4 $a Molecular biology. $3 517296
650 4 $a Biochemistry. $3 518028
650 4 $a Intubation. $3 1363440
650 4 $a Research. $3 531893
650 4 $a Ventilators. $3 3685015
650 4 $a Task forces. $3 3680558
650 4 $a Thoracic surgery. $3 3685016
650 4 $a Mortality. $3 533218
650 4 $a Heart failure. $3 804127
650 4 $a Pediatrics. $3 559143
650 4 $a Drug dosages. $3 3557732
650 4 $a Patients. $3 1961957
650 4 $a Heart surgery. $3 3681537
650 4 $a Age. $3 1486010
650 4 $a Liver. $3 3564653
650 4 $a Obstetrics. $3 634501
650 4 $a Coronary vessels. $3 3680599
650 4 $a Veins & arteries. $3 3681939
650 4 $a Nitric oxide. $3 750512
650 4 $a Intensive care. $2 gtt $3 1068710
650 4 $a Pulmonary arteries. $3 3685017
650 4 $a Systematic review. $3 3680549
650 4 $a Males. $3 3562279
650 4 $a Critical care. $3 3685018
650 4 $a Heart rate. $3 3563099
650 4 $a Weaning. $3 3685019
653 $a General anesthesia
653 $a Nitric oxide
653 $a Prostacyclin
653 $a Intraoperative management
653 $a Pulmonary hypertension
690 $a 0569
690 $a 0576
690 $a 0487
690 $a 0419
690 $a 0307
690 $a 0380
700 1 0 $a Lyles, Raven $e joint author $3 3685013
710 2 $a Franciscan Missionaries of Our Lady University. $b School of Nursing. $3 3685014
773 0 $t Dissertations Abstracts International $g 83-02B.
790 $a 2035
791 $a D.N.P.
792 $a 2021
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28643961